Floatz logo

Polio Vaccine

Colorectal Adenocarcinoma

National Cancer Institute (NCI)vaccinePhase 1Active
C
37/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
25/ 100
Competitive Position
73/ 100

Competitive context

49 Active assets in the Colorectal Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Eloxatin
Pfizer
Phase 3BB
FLUOROURACILUM
Centre Hospitalier Universitaire Dijon
Phase 3BB
Calcium folinate pentahydrate
Centre Hospitalier Universitaire Dijon
Phase 3BB
Cetuximab
Bayer
Phase 2BB
(+)-VINCRISTINE
Pfizer
Phase 3B

View all 50 →

Same molecule, other indications

Polio Vaccine is also rated in:

Immunity to Polio Vaccines in Malnourished InfantsDormant
B
Indicative ·
56 / 100
View asset →
urinary bladder carcinomaDormant
CCC
Indicative ·
49 / 100
View asset →
colon carcinomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →